Filing metadata

Accession number
0001140361-22-047070
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Dec 27, 2022
Reporting period
Dec 22, 2022
Description
Insider transaction

Explore SEC Filings Hub